Immunovant, Inc. IMVT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s deferred tax assets and other non-current assets?
- Immunovant, Inc. (IMVT) reported deferred tax assets and other non-current assets of $7.68M in Q1 2026.
- How has Immunovant, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Immunovant, Inc.'s deferred tax assets and other non-current assets increased by 0.8% year-over-year, from $7.62M to $7.68M.